Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$49.7 - $57.71 $480,300 - $557,709
9,664 Added 175.36%
15,175 $773,000
Q3 2022

Nov 14, 2022

BUY
$53.86 - $66.8 $19,281 - $23,914
358 Added 6.95%
5,511 $297,000
Q1 2022

May 06, 2022

SELL
$76.85 - $89.45 $14,832 - $17,263
-193 Reduced 3.61%
5,153 $400,000
Q4 2021

Jan 26, 2022

SELL
$74.57 - $87.19 $17,523 - $20,489
-235 Reduced 4.21%
5,346 $459,000
Q3 2021

Oct 20, 2021

BUY
$73.77 - $83.61 $10,991 - $12,457
149 Added 2.74%
5,581 $449,000
Q4 2020

Feb 11, 2021

SELL
$75.39 - $82.36 $980 - $1,070
-13 Reduced 0.24%
5,432 $436,000
Q3 2020

Nov 10, 2020

BUY
$78.33 - $90.73 $1,018 - $1,179
13 Added 0.24%
5,445 $438,000
Q1 2020

May 11, 2020

BUY
$71.57 - $93.3 $18,966 - $24,724
265 Added 5.13%
5,432 $441,000
Q4 2019

Feb 13, 2020

BUY
$76.7 - $88.45 $13,729 - $15,832
179 Added 3.59%
5,167 $432,000
Q3 2019

Nov 12, 2019

BUY
$81.4 - $89.78 $47,212 - $52,072
580 Added 13.16%
4,988 $436,000
Q2 2019

Aug 13, 2019

SELL
$73.44 - $82.41 $9,914 - $11,125
-135 Reduced 2.97%
4,408 $361,000
Q1 2019

May 15, 2019

SELL
$64.48 - $81.31 $204,079 - $257,346
-3,165 Reduced 41.06%
4,543 $369,000
Q4 2018

Feb 13, 2019

BUY
$61.45 - $77.8 $98,012 - $124,091
1,595 Added 26.09%
7,708 $507,000
Q3 2018

Nov 14, 2018

BUY
$70.71 - $77.75 $217,362 - $239,003
3,074 Added 101.15%
6,113 $471,000
Q2 2018

Aug 13, 2018

BUY
$63.43 - $75.41 $192,763 - $229,170
3,039 New
3,039 $0
Q1 2018

May 14, 2018

SELL
$62.56 - $72.26 $206,948 - $239,036
-3,308 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$61.45 - $66.05 $203,276 - $218,493
3,308
3,308 $214,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Rmb Capital Management, LLC Portfolio

Follow Rmb Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmb Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rmb Capital Management, LLC with notifications on news.